Analysis of HIF-prolyl hydroxylases binding to substrates

被引:32
|
作者
Landazuri, Manuel O.
Vara-Vega, Alicia
Viton, Mariano
Cuevas, Yolanda
del Peso, Luis
机构
[1] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid 28029, Spain
[2] Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Madrid 28029, Spain
关键词
HIF; EGLN; PHD; hypoxia; proline-hydroxylation; VHL;
D O I
10.1016/j.bbrc.2006.09.170
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia inducible transcription factors (HIF) are mainly regulated by a group of proline hydroxylases (EGLNs) that, in the presence of oxygen, target HIF for degradation. HIF alpha contains two independent oxygen degradation domains (N-ODD and C-ODD) that are substrates for these enzymes. In this work, we employed the yeast two-hybrid assay to study the sequence determinants required for the binding of EGLN1 and 3 to HIF1 alpha in a cellular context. Our results demonstrate that, while EGLN1 is able to recognize both ODDs within full length HIF1 alpha protein, EGLN3 only binds to CODD. The analysis of the residue substitutions within CODD uncovered novel critical determinants for EGLN1 and 3 binding. In addition, our results show that both enzymes have a very similar, albeit not identical, residue preference at specific positions in their substrate sequences. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [41] Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety"
    Yamamoto, Hiroyasu
    Nobori, Kiyoshi
    Matsuda, Yoshimi
    Hayashi, Yasuhiro
    Hayasaki, Takanori
    Akizawa, Tadao
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2022, 52 (12) : 977 - 978
  • [42] Myeloid HIF-Prolyl Hydroxylase Proteins in Human and Mouse Atherosclerosis: Triplets with Differing Characters
    Demandt, Jasper
    van Kuijk, Kim
    Theelen, Thomas
    Marsch, Elke
    de Bruijn, Jenny
    Gijbels, Marion
    Matic, Ljubica
    Reutelingsperger, Chris
    Cosemans, Judith
    Hedin, Ulf
    Biessen, Erik
    Daemen, Mat
    Carmeliet, Peter
    Schurgers, Leon
    Sluimer, Judith C.
    [J]. JOURNAL OF VASCULAR RESEARCH, 2019, 56 : 28 - 28
  • [43] HIF-independent role of prolyl hydroxylases in the cellular response to amino acids
    R V Durán
    E D MacKenzie
    H Boulahbel
    C Frezza
    L Heiserich
    S Tardito
    O Bussolati
    S Rocha
    M N Hall
    E Gottlieb
    [J]. Oncogene, 2013, 32 : 4549 - 4556
  • [44] The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer
    Yu, Mengchao
    Lun, Jie
    Zhang, Hongwei
    Zhu, Lei
    Zhang, Gang
    Fang, Jing
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2021, 135
  • [45] Microbiota-derived butyrate is an endogenous inhibitor of HIF prolyl-hydroxylases
    Wang, Ruth
    Henen, Morkos
    Lee, J.
    Vogeli, Beat
    Colgan, Sean
    [J]. FASEB JOURNAL, 2021, 35
  • [46] HIF-independent role of prolyl hydroxylases in the cellular response to amino acids
    Duran, R. V.
    MacKenzie, E. D.
    Boulahbel, H.
    Frezza, C.
    Heiserich, L.
    Tardito, S.
    Bussolati, O.
    Rocha, S.
    Hall, M. N.
    Gottlieb, E.
    [J]. ONCOGENE, 2013, 32 (38) : 4549 - 4556
  • [47] Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia
    Jatho, Aline
    Zieseniss, Anke
    Brechtel-Curth, Katja
    Yamamoto, Atsushi
    Coleman, Mathew L.
    Vergel Leon, Ana M.
    Biggs, Daniel
    Davies, Ben
    Pugh, Chris W.
    Ratcliffe, Peter J.
    Katschinski, Doerthe M.
    [J]. CIRCULATION RESEARCH, 2021, 128 (08) : 1208 - 1210
  • [48] Selective Small Molecule Probes for the Hypoxia Inducible Factor (HIF) Prolyl Hydroxylases
    Chowdhury, Rasheduzzaman
    Candela-Lena, Jose Ignacio
    Chan, Mun Chiang
    Greenald, David Jeremy
    Yeoh, Kar Kheng
    Tian, Ya-Min
    McDonough, Michael A.
    Tumber, Anthony
    Rose, Nathan R.
    Conejo-Garcia, Ana
    Demetriades, Marina
    Mathavan, Sinnakaruppan
    Kawamura, Akane
    Lee, Myung Kyu
    van Eeden, Freek
    Pugh, Christopher W.
    Ratciffe, Peter J.
    Schofieldt, Christopher J.
    [J]. ACS CHEMICAL BIOLOGY, 2013, 8 (07) : 1488 - 1496
  • [49] Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
    Locatelli, Francesco
    Minutolo, Roberto
    De Nicola, Luca
    Del Vecchio, Lucia
    [J]. DRUGS, 2022, 82 (16) : 1565 - 1589
  • [50] Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
    Francesco Locatelli
    Roberto Minutolo
    Luca De Nicola
    Lucia Del Vecchio
    [J]. Drugs, 2022, 82 : 1565 - 1589